MYGN - MYRIAD GENETICS INC
4.36
0.080 1.835%
Share volume: 1,342,841
Last Updated: 03-30-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.05%
PREVIOUS CLOSE
CHG
CHG%
$4.28
0.08
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-08-2024 | 02-28-2025 | 05-07-2025 | 08-06-2025 | 11-04-2025 | 02-24-2026 | |
| Total revenue | 202.200 M | 211.500 M | 213.300 M | 210.600 M | 195.900 M | 213.100 M | 205.700 M | 209.800 M | |
| Cost of revenue | 64.600 M | 64.400 M | 63.500 M | 59.700 M | 61.700 M | 61.300 M | 61.900 M | 63.000 M | |
| Gross profit | 137.600 M | 147.100 M | 149.800 M | 150.900 M | 134.200 M | 151.800 M | 143.800 M | 146.800 M | |
| 6.90% | 1.84% | 0.73% | -11.07% | 13.11% | -5.27% | 2.09% | |||
| Operating expenses | 165.500 M | 172.000 M | 167.600 M | -115.800 M | 94.000 M | 92.400 M | 96.100 M | 81.100 M | |
| Selling general and admin | 140.600 M | 144.900 M | 139.100 M | -148.700 M | 66.500 M | 66.800 M | 67.900 M | 55.600 M | |
| Research and development | 24.900 M | 27.100 M | 28.500 M | 32.900 M | 27.500 M | 25.600 M | 28.200 M | 25.500 M | |
| Total expenses | 165.500 M | 183.600 M | 169.800 M | 190.000 M | 163.200 M | 481.000 M | 167.100 M | 152.500 M | |
| 10.94% | -7.52% | 11.90% | -14.11% | 194.73% | -65.26% | -8.74% | |||
| Operating income | -27.900 M | -36.500 M | -20.000 M | -39.100 M | -29.000 M | -329.200 M | -23.300 M | -5.700 M | |
| Ebit | -26.000 M | -36.800 M | -20.800 M | -38.800 M | -28.900 M | -329.300 M | -22.900 M | -5.300 M | |
| Pretax income | -25.900 M | -37.200 M | -21.200 M | -39.200 M | -29.400 M | -330.600 M | -26.200 M | -8.900 M | |
| 43.63% | -43.01% | 84.91% | -25.00% | 1,024.49% | -92.08% | -66.03% | |||
| Income tax | 100.000 K | -500.000 K | 900.000 K | 3.300 M | -29.300 M | -100.000 K | 1.200 M | -1.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -26.000 M | -36.700 M | -22.100 M | -42.500 M | -100.000 K | -330.500 M | -27.400 M | -7.900 M | |
| -41.15% | 39.78% | -92.31% | 99.76% | -330,400.00% | 91.71% | 71.17% |